Guggenheim Capital LLC Cytokinetics Inc Transaction History

Guggenheim Capital LLC

  • $10.6 Billion
  • Q1 2025

A detailed history of Guggenheim Capital LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 36,703 shares of CYTK stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,703
Previous 35,988 1.99%
Holding current value
$1.13 Million
Previous $1.69 Million 12.83%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$40.19 - $51.12 $28,735 - $36,550
715 Added 1.99%
36,703 $1.48 Million
Q4 2024

Feb 13, 2025
SELL
$46.36 - $58.62 $227,071 - $287,120
-4,898 Reduced 11.98%
35,988 $1.69 Million
Q3 2024

Nov 13, 2024
SELL
$51.22 - $60.16 $11,985 - $14,077
-234 Reduced 0.57%
40,886 $2.16 Million
Q2 2024

Aug 14, 2024
SELL
$47.86 - $75.05 $26,227 - $41,127
-548 Reduced 1.32%
41,120 $2.23 Million
Q1 2024

May 14, 2024
SELL
$63.75 - $108.06 $162,817 - $275,985
-2,554 Reduced 5.78%
41,668 $2.92 Million
Q4 2023

Feb 14, 2024
SELL
$26.88 - $83.49 $182,246 - $566,062
-6,780 Reduced 13.29%
44,222 $3.69 Million
Q3 2023

Nov 14, 2023
SELL
$29.46 - $36.61 $34,556 - $42,943
-1,173 Reduced 2.25%
51,002 $1.5 Million
Q2 2023

Aug 11, 2023
BUY
$32.62 - $40.75 $39,763 - $49,674
1,219 Added 2.39%
52,175 $1.7 Million
Q1 2023

May 10, 2023
SELL
$33.36 - $45.71 $258,740 - $354,526
-7,756 Reduced 13.21%
50,956 $1.79 Million
Q4 2022

Feb 14, 2023
BUY
$35.77 - $51.11 $810,905 - $1.16 Million
22,670 Added 62.9%
58,712 $2.69 Million
Q3 2022

Nov 14, 2022
BUY
$38.54 - $54.52 $1.39 Million - $1.97 Million
36,042 New
36,042 $1.75 Million
Q2 2021

Aug 13, 2021
SELL
$19.79 - $26.99 $186,223 - $253,975
-9,410 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$18.57 - $25.68 $173,908 - $240,493
-9,365 Reduced 49.88%
9,410 $219,000
Q4 2020

Feb 16, 2021
BUY
$15.26 - $28.61 $286,506 - $537,152
18,775 New
18,775 $390,000
Q4 2017

Feb 14, 2018
SELL
$7.25 - $15.65 $895,056 - $1.93 Million
-123,456 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$12.0 - $15.0 $1.48 Million - $1.85 Million
123,456
123,456 $1.79 Million

Others Institutions Holding CYTK

# of Institutions
408
Shares Held
127M
Call Options Held
3.66M
Put Options Held
900K
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $2.89B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email